NII grew by 14.38 per cent and came in at Rs. 1,424 crore. PAT grew to Rs. 1,044 crore.

After Yes Bank, here comes yet another action on a private sector bank. The  Reserve Bank of India (RBI) has barred Bandhan Bank from opening new branches and has also freezed the compensation of its  CEO.

At 12.30 pm, the HFC's saw decline of more than 20% across the board. The pack was led by DHFL which corrected by more than 50% followed by YES bank which fell  by more than 25%. 

TVS Motor Company announced its association with leading distributor in the Mexican region, Torino Motors, a subsidiary of Groupo Autofin.

HFCL has received an advance purchase order worth nearly Rs 611 crore from Bharat Sanchar Nigam Limited (BSNL)

Yes Bank has successfully closed a USD 400 million syndicated loan facility, borrowed out of the Bank’s IFSC Banking Unit (IBU) in Gujarat International Finance Tec City (GIFT) and will be utilised to support the IBU’s growing business.

Aurobindo Pharma Ltd's wholly-owned subsidiary, Aurobindo Pharma USA Incorporated signed a definitive agreement to acquire commercial operations and three manufacturing facilities related to dermatology and oral solids businesses in US from Sandoz Inc., USA, a Novartis Division.

Centrum Financial Services Limited signed an agreement to acquire L&T Finance's Supply Chain Finance business on Wednesday. The supply chain vertical provides working capital finance to entities that are suppliers to large industrial manufacturers and Original Equipment Manufacturers (OEMs). The company also provide channel finance and inventory finance to dealers. Its combined customer base is nearly about 800.

Timken India Limited, a subsidiary of The Timken Company announced the completion of ABC Bearings Limited's acquisition. The two companies, ABC Bearings Limited and Timken India Limited were merged by way of exchange of shares.

Panacea Biotec Ltd. announced that it has entered into a tripartite agreement with Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc. for the manufacture and supply of Azacitidine injection for the US market under Breckenridge's already-Approved New Drugs Application (ANDA).